DRI Healthcare Trust (TSE:DHT) Downgraded by Raymond James to Moderate Buy

DRI Healthcare Trust (TSE:DHT) was downgraded by analysts at Raymond James from a “strong-buy” rating to a “moderate buy” rating in a research note issued on Monday, Zacks.com reports.

Separately, Scotiabank upgraded shares of DRI Healthcare Trust to a “strong-buy” rating in a report on Friday, June 14th.

DRI Healthcare Trust Price Performance

DRI Healthcare Trust (TSE:DHT) last released its quarterly earnings results on Monday, May 6th. The company reported C$0.57 earnings per share for the quarter, missing analysts’ consensus estimates of C$0.66 by C($0.09). The company had revenue of C$56.71 million for the quarter, compared to the consensus estimate of C$55.13 million.

Insider Buying and Selling

In other DRI Healthcare Trust news, insider DRI Capital Inc. bought 75,000 shares of DRI Healthcare Trust stock in a transaction dated Wednesday, May 8th. The stock was purchased at an average price of C$11.95 per share, for a total transaction of C$896,250.00.

DRI Healthcare Trust Company Profile

DHT is an independent crude oil tanker company. Its fleet trades internationally and consists of crude oil tankers in the VLCC segment. It operates through its integrated management companies in Monaco, Singapore and Oslo, Norway. You shall recognize it by its business approach with an experienced organization with focus on first rate operations and customer service, quality ships built at quality shipyards, prudent capital structure with robust cash break even levels to accommodate staying power through the business cycles, a combination of market exposure and fixed income contracts for its fleet and a transparent corporate structure maintaining a high level of integrity and good governance.